Stay updated with breaking news from Eyepoint pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEWTON SQUARE, Pa., April 22, 2024 (GLOBE NEWSWIRE) ArriVent BioPharma, Inc., a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of ....
WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing. ....
WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and. ....
InvoX Pharma, a Sino Biopharm subsidiary, will pay $161 million to acquire F-Star, a Cambridge, UK clinical-stage company developing bispecific drugs for immunotherapies. ....
WATERTOWN, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and. ....